Michael E. Thase, MD, MSc

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Corporal Michael J Cresencz VAMC, Philadelphia, Pennsylvania

  • 184Articles
  • 769.9KReads1
  • 1997–2026Active
  • 453Collaborators
  • 3.7KCitations2

About

Michael E. Thase, MD, is affiliated with the Corporal Michael J Cresencz VAMC and the Department of Psychiatry at the Perelman School of Medicine, University of Pennsylvania. His extensive publication record since 1997 includes research on major depressive disorder, bipolar disorder, schizophrenia and schizoaffective disorders, neurology, psychiatry, psychopharmacology, patient care, and suicide. His work addresses topics such as antidepressant treatment effects, cognitive behavioral therapy for relapse prevention, treatment-resistant depression, deprescribing, and patient functioning and life engagement across psychiatric conditions. Dr. Thase has frequently collaborated with Madhukar H. Trivedi, A. John Rush, Maurizio Fava, Martin B. Keller, and Andrew A. Nierenberg.

Publications

JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Academic Highlights

Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia

August 3, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
, , , et al
JCP
In Memoriam

In Memoriam: Aaron T. Beck, MD

January 4, 2022

Aaron T. Beck, founding father of Cognitive Therapy, was ranked the fourth most influential person in the history of medicine in a 2016 survey. Colleague and friend Michael Thase...
JCP
Original Research

Adjunctive Pimavanserin and Sleep/Wakefulness in MDD

December 1, 2020

Adjunctive pimavanserin can reduce depressive symptoms and improve function in patients with major depression and inadequate antidepressant response. This analysis evaluated the effects of adjunctive pimavanserin on sleep/wakefulness disturbances.
, , , et al
JCP
Original Research

Utility of Combinatorial Pharmacogenomics in Depression

October 31, 2019

This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...
, , , et al
JCP
Original Research

Adjunctive Pimavanserin in Treatment-Resistant MDD

September 24, 2019

The use of atypical antipsychotics as adjunctive treatment for nonresponsive depression is limited by their side effects. This study explores whether pimavanserin can be both an efficacious and tolerable...
, , , et al
JCP
Meta-Analysis

Computer-Assisted CBT for Depression

March 19, 2019

Computer-assisted cognitive-behavior therapy (CCBT) allows clinicians to deliver evidence-based care to more patients than would be possible with standard CBT. This meta-analysis sought to determine if additional clinician support...
, , , et al
JCP
Educational Activity

Addressing Unmet Needs in MDD

February 20, 2019

Most people who experience a depressive episode are greatly impaired by it. No one-size-fits-all therapy is available, and most patients require multiple treatment steps. Check out this CME activity...
JCP
Commentary

Commentary

July 5, 2018

This commentary by Michael E. Thase, MD, discusses the article "Antipsychotic Medication Treatment Patterns in Adult Depression" by Gerhard et al.
PCC
Article

Computer-Assisted CBT for Depression in Primary Care

March 1, 2018

Can a computer program help primary care clinicians and their patients in treatment of depression? This systematic review of eight studies of computer-assisted cognitive-behavior therapy found that computerized delivery...
, , , et al
JCP
ASCP Corner

A Note From the ASCP President

February 21, 2018

JCP
Academic Highlights

Utilizing the DSM-5 Anxious Distress Specifier to Develop Treatment Strategies for Patients With Major Depressive Disorder

November 28, 2017

Many of your patients with depression also experience anxiety symptoms, and addressing these symptoms is a crucial part of successful treatment. Explore this free Academic Highlights activity to learn...
, , , et al
JCP
Meta-Analysis

Antidepressant Effects of Sleep Deprivation

September 19, 2017

Acute sleep deprivation is one of the most rapid antidepressant interventions known; however, its benefits are usually short-lived. This meta-analysis synthesizes the existing data on acute sleep deprivation in...
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
Clinical psychologist Jenny Guidi discussing DCPR advancements in psychiatry

Subscribe to read
more articles

Subscribe